{"entity":{"type":"insider","cik":"0001588861","url":"/insider/0001588861","json_url":"/insider/0001588861.json","name":"Shah Sujal","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":14,"first":"2014-09-17","last":"2023-12-11","span_basis":"filed_date"},"name_variants":[{"name":"Shah Sujal","source":"filing","n_filings":14,"first_seen":"2014-09-17","last_seen":"2023-12-11"}],"transactions":[{"id":8647974,"accession":"0001062993-23-022368","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-23-022368","line_url":"/filing/0001062993-23-022368","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64865.0,"shares_display":"64,865","price_per_share":19.997996338549296,"price_display":"20.00","price_state":"stated","total_value":1297170.0325,"total_display":"1,297,170.03","total_whole":"1,297,170","shares_owned_after":171301.0,"shares_owned_after_display":"171,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-11","scope":"insider","n_lines":2},{"id":8578995,"accession":"0001062993-23-020835","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-23-020835","line_url":"/filing/0001062993-23-020835","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64863.0,"shares_display":"64,863","price_per_share":15.889792647580284,"price_display":"15.89","price_state":"stated","total_value":1030659.6205,"total_display":"1,030,659.62","total_whole":"1,030,660","shares_owned_after":171301.0,"shares_owned_after_display":"171,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-14","scope":"insider","n_lines":2},{"id":7859569,"accession":"0001062993-23-019205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-019205","line_url":"/filing/0001062993-23-019205#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64861.0,"shares_display":"64,861","price_per_share":14.204,"price_display":"14.20","price_state":"stated","total_value":921285.644,"total_display":"921,285.64","total_whole":"921,286","shares_owned_after":171301.0,"shares_owned_after_display":"171,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-09","filed_date":"2023-10-10","scope":"insider"},{"id":6744426,"accession":"0001062993-22-014432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-014432","line_url":"/filing/0001062993-22-014432#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51301.0,"shares_display":"51,301","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":100036.95,"total_display":"100,036.95","total_whole":"100,037","shares_owned_after":171301.0,"shares_owned_after_display":"171,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-07","scope":"insider"},{"id":7882396,"accession":"0001333277-19-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001333277-19-000046","line_url":"/filing/0001333277-19-000046#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.3,"price_display":"4.30","price_state":"stated","total_value":21500.0,"total_display":"21,500.00","total_whole":"21,500","shares_owned_after":120000.0,"shares_owned_after_display":"120,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-10","filed_date":"2019-10-15","scope":"insider"},{"id":8259336,"accession":"0001333277-19-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001333277-19-000044","line_url":"/filing/0001333277-19-000044#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3100.0,"shares_display":"3,100","price_per_share":5.55,"price_display":"5.55","price_state":"stated","total_value":17205.0,"total_display":"17,205.00","total_whole":"17,205","shares_owned_after":115000.0,"shares_owned_after_display":"115,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-24","scope":"insider"},{"id":8259330,"accession":"0001333277-19-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001333277-19-000044","line_url":"/filing/0001333277-19-000044#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":10450.0,"total_display":"10,450.00","total_whole":"10,450","shares_owned_after":111900.0,"shares_owned_after_display":"111,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":6876568,"accession":"0001333277-18-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001333277-18-000041","line_url":"/filing/0001333277-18-000041#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.5399,"price_display":"6.54","price_state":"stated","total_value":65399.0,"total_display":"65,399.00","total_whole":"65,399","shares_owned_after":110000.0,"shares_owned_after_display":"110,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-21","filed_date":"2018-12-21","scope":"insider"},{"id":6400538,"accession":"0001333277-18-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001333277-18-000040","line_url":"/filing/0001333277-18-000040#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":9.9,"price_display":"9.90","price_state":"stated","total_value":49500.0,"total_display":"49,500.00","total_whole":"49,500","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-16","scope":"insider"},{"id":6085877,"accession":"0001333277-18-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001333277-18-000037","line_url":"/filing/0001333277-18-000037#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":10.9,"price_display":"10.90","price_state":"stated","total_value":54500.0,"total_display":"54,500.00","total_whole":"54,500","shares_owned_after":95000.0,"shares_owned_after_display":"95,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-27","filed_date":"2018-07-30","scope":"insider"},{"id":6485246,"accession":"0001333277-18-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001333277-18-000036","line_url":"/filing/0001333277-18-000036#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":10.65,"price_display":"10.65","price_state":"stated","total_value":53250.0,"total_display":"53,250.00","total_whole":"53,250","shares_owned_after":90000.0,"shares_owned_after_display":"90,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-11","filed_date":"2018-05-15","scope":"insider"},{"id":4870841,"accession":"0001209191-17-046040","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-046040","line_url":"/filing/0001209191-17-046040","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Director, Officer (Interim President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.34005,"price_display":"7.34","price_state":"stated","total_value":73400.5,"total_display":"73,400.50","total_whole":"73,401","shares_owned_after":85000.0,"shares_owned_after_display":"85,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-24","scope":"insider","n_lines":5},{"id":2870713,"accession":"0001179110-16-022848","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-16-022848","line_url":"/filing/0001179110-16-022848#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33000.0,"shares_display":"33,000","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":45870.0,"total_display":"45,870.00","total_whole":"45,870","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-05","filed_date":"2016-04-06","scope":"insider"},{"id":2870705,"accession":"0001179110-16-022848","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-022848","line_url":"/filing/0001179110-16-022848#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":30580.0,"total_display":"30,580.00","total_whole":"30,580","shares_owned_after":42000.0,"shares_owned_after_display":"42,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-04","filed_date":"2016-04-06","scope":"insider"},{"id":8810493,"accession":"0001179110-15-008138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-008138","line_url":"/filing/0001179110-15-008138#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":34000.0,"total_display":"34,000.00","total_whole":"34,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-18","filed_date":"2015-05-19","scope":"insider"},{"id":6608365,"accession":"0001179110-14-014264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-014264","line_url":"/filing/0001179110-14-014264#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588861","owner_name":"Shah Sujal","owner_display_name":"Shah Sujal","owner_url":"/insider/0001588861","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.44,"price_display":"7.44","price_state":"stated","total_value":74400.0,"total_display":"74,400.00","total_whole":"74,400","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-16","filed_date":"2014-09-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":17,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001042074","name":"CymaBay Therapeutics, Inc.","url":"/issuer/0001042074","role":"Director, Officer (Chief Executive Officer)","n_filings":14,"first_seen":"2014-09-17","last_seen":"2023-12-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001588861","retrieved_at":"2026-08-27T04:15:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}